Unique ID issued by UMIN | UMIN000042438 |
---|---|
Receipt number | R000048447 |
Scientific Title | Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers |
Date of disclosure of the study information | 2020/11/13 |
Last modified on | 2021/11/15 08:27:28 |
Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers
Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers
Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers
Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers
Japan |
Healthy Volunteer
Adult |
Others
NO
Evaluate the changes in activity after intake of foods containing SNR14 and feasibility of tests using wristwatch-type devices.
Efficacy
Amount of activity (physical activity intensity (METs), number of steps, speed, time, location information (GPS))
(Exploratory measurement item)
Heart rate, sleep quality (sleep score, sleep time, sleep interruption time), body composition (weight, body water content, muscle mass, body fat mass, body fat percentage, basal metabolic rate, visceral fat level), grip strength, health related QOL, weather , temperature, humidity
(Safety evaluation)
General physical findings (subjective symptoms, objective findings), vital signs (weight, body temperature, blood pressure, pulse rate), blood test items, urinalysis items, frequency of adverse events
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
2-weeks intake of SNR14-containing food
2-weeks intake of the placebo food
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1)Subjects who have obtained written consent for participation in the research.
2)Healthy men and women aged between 20 and 60.
3)Subjects who can take test foods, etc., take blood samples, take urine samples, and stay quiet and rest on the schedule indicated by investigators.
1)Subjects whose clinical inspection results are outside of the normal range and who are estimated inappropriate to this study.
2)Subjects who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study.
3)As a general rule, those who regularly use drugs for the purpose of treating diseases.
4)Subjects who have allergy.
5)Lactating people, pregnant women or those who may be pregnant, and those who wish to become pregnant during the study period.
6)Subjects who are estimated inappropriate to this study by principal investigator or investigators.
30
1st name | Yasutaka |
Middle name | |
Last name | Ikeda |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Aza Higashiyama, Omagari, Yoshinogari-cho Kanzakigun, Saga, Japan
0952-52-1522
Ikeda.Yasutaka@otsuka.jp
1st name | Tsubasa |
Middle name | |
Last name | Mizokami |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Aza Higashiyama, Omagari, Yoshinogari-cho Kanzakigun, Saga
0952-52-1522
Mizokami.Tsubasa@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Profit organization
Physical Education and Medicine Research Foundation
Otsuka Pharmaceutical Co., Ltd.
Shinagawa Grand Central Tower, 2-16-4, Konan, Minato-ku, Tokyo
03-6717-1499
shimizu_se@otsuka.jp
NO
2020 | Year | 11 | Month | 13 | Day |
Unpublished
Completed
2020 | Year | 11 | Month | 02 | Day |
2020 | Year | 11 | Month | 02 | Day |
2020 | Year | 11 | Month | 07 | Day |
2020 | Year | 12 | Month | 31 | Day |
2020 | Year | 11 | Month | 13 | Day |
2021 | Year | 11 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048447
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |